Zetia, Ezetimibe News

On May 3, 2013, the FDA approved a Big Pharma Cartel founding member Merck drug Liptruzet.

I have discussed Vytorin several times before. The combination of Zetia , the cholesterol absorption inhibitor discovered at Schering-Plough, with Merck's simvastatin looked as if it should be a very effective cholesterol-lowering medication, but the real-world data have been consistently puzzling .

Liptruzet , a combination drug developed by Merck that has been found to lower a patient's low-density lipoprotein cholesterol levels, has been approved by the US Food and Drug Administration .

The FDA has approved a new ezetimibe-atorvastatin tablet for lowering cholesterol in patients with primary or mixed hyperlipidemia, and in those with homozygous familial hypercholesterolemia.

Main Category: Cardiovascular / Cardiology Also Included In: Statins ; Cholesterol ; Regulatory Affairs / Drug Approvals Article Date: 05 May 2013 - 0:00 PDT Liptruzet, a cholesterol-lowering drug that combines Merck's Zetia with atorvastatin has been approved by the US FDA .

LIPTRUZET contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one of the most widely prescribed statins in the U.S.1 Once-daily LIPTRUZET treats two sources of cholesterol by inhibiting both the absorption of cholesterol in the digestive tract - through ezetimibe - and the production of cholesterol in ... (more)

FDA Approves Merck & Co., Inc. 's LIPTRUZET , a New Product That Can Help Powerfully Lower LDL Cholesterol Staying up-to-date has never been simpler.

The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday.

Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2013.

Nauman is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.